Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent versus daily oral ferrous fumarate in pregnant women with iron deficiency anaemia
NL-OMON51243Phase 4Completed
- Sponsor
- Martini Ziekenhuis
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ferrous fumarate in iron deficiency anemia (IDA), sponsored by Martini Ziekenhuis. Started Jan 2022; status: completed.
02
Drugs
ferrous fumarate
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NL-OMON51243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51243.